In September 2012, the US FDA approved some label changes for Multaq, including certain types of lung disease and pulmonary toxicity as serious side effects of the drug. Multaq (Dronedarone) is a drug...
(PRWeb October 31, 2012)
Read the full story at http://www.prweb.com/releases/2012/10/prweb10066611.htm